Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 1, 1989Journal of Clinical Oncology

Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. Lung Cancer Working Party, Belgium.

View Full Paper
Ask AI
Bookmark
Share

Authors

JKJean KlášterskýUniversité Libre de BruxellesJSJean‐Paul SculierUniversité Libre de BruxellesGBG. BureauInstitut Jules Bordet

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Klášterský et al. (1989) studied this question.

synapsesocial.com/papers/6a0fcbc192676d5461fd1793https://doi.org/10.1200/jco.1989.7.8.1087
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1An Improved Approximate Formula for Calculating Sample Sizes for Comparing Two Binomial Distributions1978 · 441 citations
  2. 2A randomized study comparing a high and a standard dose of cisplatin in combination with etoposide in the treatment of advanced non-small-cell lung carcinoma.1986 · 136 citations
  3. 3Combination chemotherapy with cisplatin and etoposide in bronchogenic squamous cell carcinoma and adenocarcinoma. A study by the EORTC lung cancer working party (Belgium)1982 · 121 citations
  4. 4Cisplatin and Vindesine Combination Chemotherapy for Advanced Carcinoma of the Lung: A Randomized Trial Investigating Two Dosage Schedules1981 · 366 citations